Order results by:
Issue | Title | |
Vol 3, No 1 (2011) | Clinical experience with Neurox used in patients with cerebrovascular disease | Abstract similar documents |
N. G. Mayorova, V. A. Pavlov | ||
"... (Neurox) used as a component of combination therapy in 32 patients with cerebrovascular diseases (CVD): 10 ..." | ||
Vol 2, No 1 (2010) | SUCCINIC ACID DERIVATIVES IN THERAPY FOR CEREBROVASCULAR DISEASE | Abstract similar documents |
N. V. Pizova | ||
"... The paper describes the effects of succinic acid derivatives, such as the new drug Neurox, used ..." | ||
Vol 10, No 1 (2018) | Chronic cerebrovascular diseases: pathogenetic mechanisms, clinical manifestations, and approaches to therapy | Abstract similar documents |
N. V. Pizova | ||
"... The paper gives data on the incidence of cerebrovascular diseases (CVD) and the pathogenetic ..." | ||
Vol 12, No 5 (2020) | The etiology, manifestations, and therapy of chronic cerebrovascular diseases | Abstract similar documents |
A. G. Gogoleva, V. V. Zakharov | ||
"... (CVD) and discusses the role of hypertension, cerebral amyloid angiopathy, and genetically determined ..." | ||
Vol 4, No 1 (2012) | Current approaches to therapy for chronic forms of cerebrovascular diseases | Abstract similar documents |
Maksim Alekseyevich Domashenko, M Yu Maksimova, T A Popova, M M Tanashyan | ||
"... diseases (CVD). The combined treatment of patients with chronic CVD comprises antiaggregants (in patients ..." | ||
Vol 13, No 1 (2021) | Chronic cerebral ischemia and headache in patients in primary care physician's practice | Abstract similar documents |
V. N. Shishkova, T. V. Adasheva | ||
"... covers in depth the spectrum of therapeutic effects of Neurox® (ethylmethylhydroxypyridine succinate ..." | ||
Vol 15, No 4 (2023) | The role of trimethylamine-N-oxide in the development of cerebrovascular disease (brief review) | Abstract similar documents |
M. A. Kutlubaev, A. R. Rakhmatullin, R. F. Kutlubaeva | ||
"... precursors. Future research should clarify the role of TMO in the development of cerebrovascular disease (CVD ..." | ||
Vol 10, No 4 (2018) | Chronic cerebrovascular diseases: use of vinpocetine in neurological practice (Round Table proceedings) | Abstract similar documents |
V. A. Parfenov, S. A. Zhivolupov, V. V. Zakharov, L. A. Belova, O. V. Lagoda, R. G. Esin, N. V. Vakhnina, I. N. Samartsev | ||
"... of chronic cerebrovascular disease (CVD) were considered. The authors analyze clinical trials evaluating ..." | ||
Vol 15, No 1 (2023) | Adherence to treatment in patients with cerebrovascular disease as a multifactorial problem | Abstract similar documents |
M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, A. A. Kornilova, E. P. Shchukina | ||
"... of adherence in cerebrovascular disease (CVD), depending on the clinical picture of the disease and comorbid ..." | ||
Vol 15, No 1 (2023) | New possibilities for the treatment of mild cognitive impairment and prevention of dementia in patients with cerebrovascular disease. Results of the PRIORITET Observation Program | Abstract similar documents |
E. Y. Solovieva, P. R. Kamchatnov, L. B. Novikova, O. A. Kicherova, N. M. Khasanova | ||
"... in the treatment of MCI in patients with cerebrovascular disease (CVD) in real clinical practice. Material ..." | ||
Vol 9, No 3 (2017) | Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program | Abstract similar documents |
G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva | ||
"... with initial manifestations of chronic cerebrovascular disease (CVD) in outpatient neurological and therapeutic ..." | ||
Vol 12, No 5 (2020) | Cognitive function dynamics in comorbid patients after angioreconstructive interventions | Abstract PDF (Eng) similar documents |
M. M. Tanashyan, K. V. Antonova, O. V. Lagoda, E. S. Berdnikovitch, R. B. Medvedev, I. I. Titkova, A. V. Naminov, A. V. Annushkin | ||
"... for cerebrovascular diseases (CVD). At the same time, their prognosis in comorbid patients, particularly in those ..." | ||
Vol 7, No 1 (2015) | Cognitive impairments in cerebrovascular disease: What is between health and dementia? | Abstract similar documents |
A. Yu. Emelin | ||
"... prevalence of both acute and chronic forms of cerebrovascular diseases (CVD). Cognitive dysfunctions ..." | ||
Vol 7, No 1 (2015) | Clinical experience with L-lysine escinate for acute and chronic cerebral circulatory disorders | Abstract similar documents |
N. V. Pizova | ||
"... Cerebrovascular diseases (CVD) are major causes of disability and death in Russia. Stroke ..." | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy) | Abstract similar documents |
V. A. Parfenov | ||
"... up with a diagnosis of CCI, DEP, have no signs of chronic cerebrovascular disease (CVD), but suffer ..." | ||
Vol 9, No 2 (2017) | Cerebrovascular disease mortality rates in the population over 50 years of age in Russia and the USA over a 15-year period | Abstract similar documents |
I. V. Samorodskaya, E. M. Andreev, O. V. Zaratyants, O. V. Kosivtsova, E. P. Kakorina | ||
"... Objective: to compare standardized mortality ratios (SMRs) from cerebrovascular diseases (CVD ..." | ||
Vol 13, No 1 (2021) | Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (pre-dementia) stage | Abstract PDF (Eng) similar documents |
A. A. Kulesh, A. Yu. Emelin, A. N. Bogolepova, O. B. Doronina, V. V. Zakharov, O. V. Kolokolov, S. V. Kotov, L. L. Korsunskaya, M. A. Kutlubaev, V. B. Laskov, O. S. Levin, V. A. Parfenov | ||
"... cerebrovascular disease (CVD) (chronic cerebral ischemia (CCI) and dyscirculatory encephalopathy (DEP)) at the pre ..." | ||
Vol 16, No 6 (2024) | Comparative efficacy of inhaled nitric oxide therapy (Tianox device) in mild cognitive impairment | Abstract similar documents |
D. A. Grishina, Yu. A. Starchina, E. A. Sokolov, V. A. Parfenov | ||
"... Chronic cerebrovascular diseases (CVD) and neurodegenerative diseases (NDD) are the most common ..." | ||
Vol 15, No 1 (2023) | Management of patients with cognitive impairment | Abstract similar documents |
V. A. Parfenov | ||
"... of cerebrovascular disease (CVD). Some non-drug and drug methods can reduce the manifestations of CI, improve ..." | ||
Vol 15, No 6 (2023) | The use of inhaled nitric oxide (Tianox device) in patients with moderate cognitive impairment | Abstract similar documents |
Yu. A. Starchina, D. A. Grishina, E. A. Sokolov, V. A. Parfenov | ||
"... due to cerebrovascular (CVD) and neurodegenerative diseases (NDD) of the brain. Material and methods ..." | ||
Vol 1, No 2 (2009) | DEPRESSION IN CEREBROVASCULAR DISEASES | Abstract similar documents |
T. G. Voznesenskaya | ||
"... Обсуждается актуальная проблема депрессии при цереброваскулярных заболеваниях. Приводятся ее ..." | ||
Vol 5, No 2S (2013): Special issue "Stroke" | Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke | Abstract similar documents |
Dina Rustemovna Khasanova, Yu V Zhitkova | ||
Vol 3, No 2 (2011) | Arterial rigidity and cerebrovascular disorders | Abstract similar documents |
L. A. Geraskina, A. V. Fonyakin, A. R. Magomedova | ||
"... первичной и вторичной профилактики цереброваскулярных заболеваний включает коррекцию факторов риска ..." | ||
Vol 13, No 1 (2021) | The role of the new coronavirus infection (COVID-19) in the progression and development of cerebrovascular diseases. A competent choice of pathogenic treatment is the key to success in treatment and prevention. An expert’s view from the ‘red zone’ | Abstract similar documents |
V. V. Kovalchuk | ||
"... COVID-19 worsens the course of cerebrovascular diseases (CVD), including chronic cerebral ..." | ||
Vol 6, No 4 (2014) | Cognitive impairments in cerebrovascular disease | Abstract similar documents |
A. Yu. Emelin | ||
"... Цереброваскулярные заболевания относятся к группе основных причин развития когнитивных нарушений ..." | ||
Vol 7, No 4 (2015) | Possibilities of using naftidrofuryl in the therapy of cerebrovascular diseases: Literature review and the authors’ observations | Abstract similar documents |
A. N. Belova, D. N. Shakurova, E. V. Gayazova | ||
"... нафтидрофурила при цереброваскулярной патологии. Нафтидрофурил является антагонистом серотониновых 5-HT2 ..." | ||
Vol 15, No 2 (2023) | Management of patients with chronic cerebrovascular disease | Abstract similar documents |
Yu. A. Starchina, O. V. Kosivtsova, E. A. Sokolov | ||
"... Цереброваскулярные заболевания – одна из самых распространенных патологий в практике врача ..." | ||
Vol 2, No 4 (2010) | Chronic ischemic cerebrovascular diseases: pathogenesis and treatment | Abstract similar documents |
N. V. Pizova, D. S. Druzhinin | ||
Vol 8, No 3 (2016) | Diagnosis and treatment of chronic cerebrovascular disease, use of pentoxifylline | Abstract PDF (Eng) similar documents |
V. A. Parfenov | ||
"... «Хроническое цереброваскулярное заболевание» (ХЦВЗ) – один из распространенных диагнозов в ..." | ||
Vol 10, No 1 (2018) | Treatment of vertigo in elderly patients with chronic cerebrovascular disease | Abstract similar documents |
S. N. Duma | ||
"... включено 89 пожилых пациентов (средний возраст – 73,7 года) с хронической цереброваскулярной патологией и ..." | ||
Vol 1, No 1 (2009) | TENOTEN IN COMPLEX THERAPY FOR CEREBROVASCULAR INSUFFICIENCY IN ELDERLY PATIENTS | Abstract similar documents |
L. D. Serova | ||
Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
"... активности. УКН наиболее часто вызваны болезнью Альцгеймера (БА) или цереброваскулярным заболеванием либо их ..." | ||
Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Influence of von Willebrand factor on common pathophysiological mechanisms of cerebrovascular diseases and multiple sclerosis | Abstract similar documents |
I. A. Koltsov, M. Yu. Martynov, A. N. Yasamanova, I. A. Shchukin, M. S. Fidler, A. N. Boyko | ||
"... вклад в развитие/прогрессирование множества заболеваний, включая цереброваскулярные болезни и рассеянный ..." | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular depression and cognitive dysfunction | Abstract similar documents |
A. N. Bogolepova | ||
"... Сосудистая депрессия является весьма частым и серьезным осложнением цереброваскулярных заболеваний ..." | ||
Vol 11, No 3 (2019) | Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? | Abstract similar documents |
G. R. Tabeeva, E. A. Kirjanova | ||
Vol 9, No 2 (2017) | Morphofunctional bases for the development of vascular cognitive and emotional disorders | Abstract similar documents |
Yu. V. Zhitkova | ||
"... Цель исследования – изучение состояния цереброваскулярной реактивности (ЦВР) и структурных ..." | ||
Vol 3, No 1 (2011) | Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program) | Abstract similar documents |
E. I. Chukanova | ||
"... цереброваскулярной недостаточностью, ассоциированной с артериальной гипертензией. Пациенты получали препарат Кавинтон ..." | ||
Vol 2, No 2 (2010) | Vertebrobasilar insufficiency: clinical and diagnostic aspects | Abstract similar documents |
S. K. Volkov | ||
"... Представлены современные методы диагностики и лечения цереброваскулярных заболеваний. Отражено ..." | ||
Vol 2, No 2 (2010) | Moderate cognitive disorders as a multidisciplinary problem | Abstract similar documents |
V. V. Zakharov | ||
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment | Abstract similar documents |
I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova | ||
"... атрофических и цереброваскулярных изменений мозговой ткани. Особое внимание уделяется специфическим признакам ..." | ||
Vol 11, No 4 (2019) | Clinical experience with piribedil in chronic cerebrovascular disease with cognitive impairment | Abstract similar documents |
E. V. Moroz, T. A. Zakharycheva, M. V. Antonyuk | ||
"... хроническим цереброваскулярным заболеванием (ХЦВЗ) и когнитивными нарушениями (КН). Пациенты и методы ..." | ||
Vol 10, No 1 (2018) | Possible mechanisms of cognitive dysfunction in patients with chronic forms of cerebrovascular diseases | Abstract similar documents |
O. N. Voskresenskaya, N. B. Zakharova, Yu. S. Tarasova, N. E. Tereshkina, V. A. Perepelov, E. M. Perepelova | ||
Vol 8, No 3 (2016) | Prevention of cerebrovascular diseases and cognitive impairment in psychiatric and neurological practice: A literature review | Abstract similar documents |
A. G. Merkin, V. A. Kazhin, A. N. Komarov, A. V. Fonarev, V. A. Priyatel, I. A. Nikiforov | ||
"... позднего возраста, такие как цереброваскулярное заболевание, инсульт, умеренное когнитивное расстройство ..." | ||
Vol 15, No 3 (2023) | Inflammatory biomarkers and growth factors in patients with chronic cerebrovascular disease after coronavirus infection | Abstract similar documents |
E. B. Kuznetsova, O. N. Voskresenskaya, N. B. Zakharova, N. S. Kuznetsov | ||
"... кровотоке у больных хроническим цереброваскулярным заболеванием (ХЦВЗ), перенесших коронавирусную инфекцию ..." | ||
Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
Vol 13, No 3 (2021) | From accurate diagnosis to targeted therapy: depression in general medical practice | Abstract similar documents |
N. N. Petrova | ||
Vol 8, No 4 (2016) | GENETIC AND FUNCTIONAL FACTORS IN THE DEVELOPMENT OF COGNITIVE IMPAIRMENT IN HYPERTENSION: A PROSPECTIVE STUDY | Abstract similar documents |
Yu. V. Zhitkova, A. A. Gasparyan, D. R. Khasanova, N. R. Khasanov, V. N. Oslopov | ||
"... , продолжительность АГ, показатели цереброваскулярной реактивности (ЦВР) и уровень пассивного трансмембранного ..." | ||
Vol 12, No 2 (2020) | The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment | Abstract similar documents |
V. A. Golovacheva | ||
"... , клинических и нейровизуализационных данных, подтверждающих наличие цереброваскулярного заболевания, на ..." | ||
Vol 10, No 1 (2018) | Headache in elderly patients with chronic cerebral ischemia: outpatient diagnosis and treatment | Abstract similar documents |
M. P. Platov, O. V. Kosivtsova | ||
"... умеренными, так и достигать уровня деменции. Примерно 40% пациентов с хроническим цереброваскулярным ..." | ||
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders | Long-term therapy for polymorphic mental disorders in liquidators of the consequences of the accident at the Chernobyl nuclear power plant | Abstract similar documents |
V. N. Krasnov, V. V. Kryukov, I. N. Emelyanova, N. Ya. Kurmysheva, M. M. Yurkin, I. A. Ryzhova, E. F. Samedova | ||
"... цереброваскулярную природу расстройств по типу умеренно выраженного психоорганического синдрома. Терапия ..." | ||
Vol 6, No 2 (2014) | Current approaches to the diagnosis, prevention, and therapy of cognitive impairments in vascular encephalopathy | Abstract similar documents |
V.Yu. Lobzin, A.Yu. Emelin, S.V. Vorobyev, I.A. Lupanov | ||
"... нарушениях – КН). Приведены особенности интеллектуально-мнестических расстройств при цереброваскулярной ..." | ||
Vol 5, No 2S (2013): Special issue "Stroke" | Post-stroke cognitive dysfunctions: A clinical and neuroimaging study | Abstract similar documents |
Andrei Yuryevich Emelin, V Yu Lobzin, S V Vorobyev, O V Dmitriev, I A Lupanov | ||
Vol 15, No 6 (2023) | Comorbidity of cerebral amyloid angiopathy and Alzheimer's disease. Clinical case analysis | Abstract similar documents |
A. Yu. Emelin, V. Yu. Lobzin, A. Yu. Efimtsev, S. V. Vorobyov | ||
"... нейродегенеративными и цереброваскулярными изменениями, оказывающими взаимоотягощающий клинический эффект. В последние ..." | ||
Vol 15, No 6 (2023) | Choline alfoscerate in the correction of cognitive impairment | Abstract similar documents |
O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova | ||
"... цереброваскулярными заболеваниями, такими как хроническая ишемия головного мозга. В составе комплексной терапии КН при ..." | ||
Vol 4, No 3 (2012) | Prevention and therapy of psychopathological disorders in patients with cardiovascular diseases | Abstract similar documents |
Vladimir Ernstovich Medvedev | ||
"... Psychopathological disorders in patients with cardiovascular diseases (CVD) are treated ..." | ||
Vol 11, No 1 (2019) | Antidepressant therapy in patients with cardiovascular diseases | Abstract similar documents |
V. E. Medvedev, E. A. Korovyakova, V. I. Frolova, E. V. Gushanskaya | ||
"... Depression is the most common form of mental illness in patients with cardiovascular diseases (CVD ..." | ||
Vol 7, No 3 (2015) | Review of the book: Fonyakin A.V., Geraskina L.A. Prevention of ischemic stroke. Guidelines for lipid-lowering therapy. Moscow: IMA-PRESS, 2015. – 72 p. | Abstract similar documents |
Е. А. Широков | ||
"... Хронические цереброваскулярные заболевания, инсульт и его последствия являются наиболее острым ..." | ||
Vol 4, No 1 (2012) | Post-stroke epilepsy: predictors, risk factors, clinical types, treatment | Abstract similar documents |
Tatyana Valeryevna Danilova, D R Khasanova, I R Kamalov | ||
"... Цереброваскулярные заболевания — один из самых частых факторов риска развития симптоматической ..." | ||
Vol 12, No 5 (2020) | Cognitive impairment, dizziness, and unsteadiness in hypertensive patients | Abstract similar documents |
L. M. Antonenko, N. V. Vakhnina, D. O. Gromova | ||
"... сосудистым факторам риска развития инсульта и хронических цереброваскулярных заболеваний. Патогенетической ..." | ||
Vol 9, No 3 (2017) | Current views of the risk factors, diagnosis, and therapy of Alzheimer's disease (according to the proceedings of the Alzheimer's Association International Conference, London, 2017) | Abstract similar documents |
N. N. Koberskaya | ||
"... исследований, факторы риска развития БА. Большое внимание было уделено взаимосвязи БА с цереброваскулярными ..." | ||
Vol 5, No 2 (2013) | Dabigatran experience in primary and secondary prevention of cardioembolic stroke | Abstract similar documents |
Maksim Alekseyevich Domashenko, M Yu Maksimova, D Z Korobkova, M E Gafarova | ||
"... 45 пациентов с цереброваскулярными заболеваниями. Большей части пациентов дабигатран назначали в ..." | ||
Vol 2, No 4 (2010) | Lost criteria | Abstract similar documents |
A. E. Manoylov | ||
"... чрезмерно упрощенным подходам к лечению цереброваскулярных заболеваний в виде кратких курсов вазоактивных и ..." | ||
Vol 2, No 2 (2010) | Possibilities of using Tanakan ® in therapy for generalized anxiety syndrome | Abstract similar documents |
D. Yu. Veltishchev | ||
"... умеренно выраженных тревожных состояниях у пожилых больных с когнитивными нарушениями цереброваскулярной ..." | ||
Vol 2, No 3 (2010) | Basic problems in the diagnosis and treatment of vestibular vertigo | Abstract similar documents |
M. V. Zamergrad | ||
"... цереброваскулярных заболеваний и дегенеративных изменений шейного отдела позвоночника в развитии головокружения, а ..." | ||
Vol 4, No 3 (2012) | Transient ischemic attack is a multidisciplinary problem | Abstract similar documents |
Valentina Vladimirovna Gudkova, T V Shanina, E A Petrova, L V Stakhovskaya | ||
"... » (ТИА), прогнозом течения цереброваскулярного заболевания после перенесенной ТИА. Указано, что вслед за ..." | ||
Vol 12, No 6 (2020) | Normal pressure hydrocephalus and cerebral amyloid angiopathy: a set of diseases or the unity of pathogenesis? | Abstract similar documents |
E. G. Mendelevich | ||
"... нейродегенеративными или цереброваскулярными патологиями, что имеет определенные диагностические сложности. Приводится ..." | ||
Vol 9, No 2 (2017) | Cognitive impairment without dementia: A current view of the problem | Abstract similar documents |
Yu. A. Starchina | ||
"... поликлиническом приеме (до 70%). КН чаще бывают вызваны болезнью Альцгеймера, цереброваскулярным заболеванием и их ..." | ||
Vol 6, No 2S (2014): Special issue "Stroke" | Cognitive reserve and cognitive impairments: drug and nondrug treatments | Abstract similar documents |
E.I. Dainikova, N.V. Pizova | ||
"... болезни Паркинсона. Обсуждаются вопросы коррекции КН при цереброваскулярной и нейродегенеративной ..." | ||
Vol 4, No 3 (2012) | Specific features of early post-stroke seizures | Abstract similar documents |
Tatyana Valeryevna Danilova, D R Khasanova, I R Kamalov | ||
"... нейровизуализационные особенности очагов ишемии, дана оценка состояния цереброваскулярной реактивности в разных ..." | ||
Vol 6, No 1 (2014) | Cerebral venous disorders: diagnosis, clinical features | Abstract similar documents |
E. I. Chukanova, A. S. Chukanova, N. D. Daniyalova | ||
"... of cerebral blood flow. Venous circulation disorders, cerebral venous dyscirculations (CVDs), as well ..." | ||
1 - 70 of 111 Items | 1 2 > >> |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)